CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.

Lopez-Carmona MD, Plaza-Seron MC, Vargas-Candela A, Tinahones FJ, Gomez-Huelgas R, Bernal-Lopez MR.

Open source

DOI
10.1186/s13098-017-0253-x
Published
2017-07-18
Container
Diabetol Metab Syndr
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13098-017-0253-x,
  title = {CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.},
  author = {Lopez-Carmona MD and  Plaza-Seron MC and  Vargas-Candela A and  Tinahones FJ and  Gomez-Huelgas R and  Bernal-Lopez MR.},
  year = {2017},
  journal = {Diabetol Metab Syndr},
  doi = {10.1186/s13098-017-0253-x},
  url = {https://doi.org/10.1186/s13098-017-0253-x}
}

RIS

TY  - JOUR
TI  - CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.
AU  - Lopez-Carmona MD
AU  -  Plaza-Seron MC
AU  -  Vargas-Candela A
AU  -  Tinahones FJ
AU  -  Gomez-Huelgas R
AU  -  Bernal-Lopez MR.
PY  - 2017
JO  - Diabetol Metab Syndr
DO  - 10.1186/s13098-017-0253-x
UR  - https://doi.org/10.1186/s13098-017-0253-x
ER  - 

APA

MD, L., MC, P., A, V., FJ, T., R, G., & MR., B. (2017). CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.. Diabetol Metab Syndr. https://doi.org/10.1186/s13098-017-0253-x

Source records